sodium glutamate has been researched along with Carcinoma 256, Walker in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akamine, EH; de Carvalho, MH; de Queiroz, EA; Fortes, ZB; Sampaio, SC | 1 |
Agostinho, AR; Barella, LF; Beraldi, EJ; de Castro Prado, MA; de Oliveira, JC; de Sant'Anna, JR; de Souza, CO; de Souza, HM; Franco, CC; Gravena, C; Malta, A; Mathias, PC; Miranda, RA; Prates, KV; Tófolo, LP; Torrezan, R; Trombini, AB | 1 |
2 other study(ies) available for sodium glutamate and Carcinoma 256, Walker
Article | Year |
---|---|
Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a.
Topics: Animals; Carcinoma 256, Walker; Cyclic AMP-Dependent Protein Kinases; Female; Food Additives; Forkhead Box Protein O3; Forkhead Transcription Factors; Hypoglycemic Agents; Male; Mammary Neoplasms, Experimental; Metformin; Obesity; Rats; Rats, Wistar; Signal Transduction; Sodium Glutamate | 2015 |
Protective effect of metformin against walker 256 tumor growth is not dependent on metabolism improvement.
Topics: Animals; Blood Glucose; Carcinoma 256, Walker; Cell Proliferation; Diabetes Mellitus, Experimental; Glucose Intolerance; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Metformin; Neoplasms; Rats; Sodium Glutamate | 2014 |